US Patent Issued to Pfizer, The Regents of the University of California, The Board of Trustees of the Leland Stanford Junior University on April 7 for "Anti-il-2 antibodies and compositions and uses thereof" (California Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,301, issued on April 7, was assigned to Pfizer Inc. (New York), The Regents of the University of California (Oakland, Calif.) and The Board of Trustees of the Leland Stanford Junior University (Stanford, Calif.).

"Anti-il-2 antibodies and compositions and uses thereof" was invented by Isaac J. Rondon (San Francisco), Natasha Crellin (San Carlos, Calif.), Paul Bessette (San Francisco), Eleonora Trotta (San Francisco), Jeffrey A. Bluestone (San Francisco), Lauren K. Ely (Palo Alto, Calif.) and Kenan C. Garcia (Menlo Park, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides antibodies, or antigen-binding portions thereo...